Breaking News, Collaborations & Alliances

Life Biosciences, Forge Biologics Partner to Advance Gene Therapies for Age-Related Diseases

Forge to provide cGMP manufacturing and development services for Life Biosciences’ novel adeno-associated virus (AAV) gene therapy platform.

Life Biosciences, a biotechnology company developing cellular rejuvenation technologies to reverse diseases of aging and injury, and Forge Biologics, a genetic medicines manufacturing organization, entered into a manufacturing partnership to help advance Life Bio’s partial epigenetic reprogramming platform to address aging-related diseases, including its lead program targeting ophthalmic indications. “Life Bio is an emerging leader in the development of novel therapies for aging-related disea...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters